Ch'ng Ewe Seng, Tuan Sharif Sharifah Emilia, Jaafar Hasnan
Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Asian Pac J Cancer Prev. 2012;13(9):4445-52. doi: 10.7314/apjcp.2012.13.9.4445.
Prognosis of breast cancer depends on classic pathological factors and also tumor angiogenesis. This study aimed to evaluate the clinicopathological factors of breast cancer in a tertiary centre with a focus on the relationship between tumor angiogenesis and clinicopathological factors.
Clinicopathological data were retrieved from the archived formal pathology reports for surgical specimens diagnosed as invasive ductal carcinoma, NOS. Microvessels were immunohistochemically stained with anti-CD34 antibody and quantified as microvessel density.
At least 50% of 94 cases of invasive breast ductal carcinoma in the study were advanced stage. The majority had poor prognosis factors such as tumor size larger than 50mm (48.9%), positive lymph node metastasis (60.6%), and tumor grade III (52.1%). Higher percentages of estrogen and progesterone receptor negative cases were recorded (46.8% and 46.8% respectively). Her-2 overexpression cases and triple negative breast cancers constituted 24.5% and 22.3% respectively. Significantly higher microvessel density was observed in the younger patient age group (p=0.012). There were no significant associations between microvessel density and other clinicopathological factors (p>0.05).
Majority of the breast cancer patients of this institution had advanced stage disease with poorer prognostic factors as compared to other local and western studies. Breast cancer in younger patients might be more proangiogenic.
乳腺癌的预后取决于经典病理因素以及肿瘤血管生成。本研究旨在评估一家三级医疗中心乳腺癌的临床病理因素,重点关注肿瘤血管生成与临床病理因素之间的关系。
从存档的正式病理报告中检索诊断为浸润性导管癌(NOS)的手术标本的临床病理数据。微血管用抗CD34抗体进行免疫组化染色,并定量为微血管密度。
本研究中94例浸润性乳腺导管癌患者中至少50%为晚期。大多数患者具有不良预后因素,如肿瘤大小大于50mm(48.9%)、淋巴结转移阳性(60.6%)和肿瘤分级为III级(52.1%)。雌激素和孕激素受体阴性病例的比例更高(分别为46.8%和46.8%)。Her-2过表达病例和三阴性乳腺癌分别占24.5%和22.3%。在年轻患者年龄组中观察到微血管密度显著更高(p=0.012)。微血管密度与其他临床病理因素之间无显著关联(p>0.05)。
与其他本地和西方研究相比,该机构的大多数乳腺癌患者处于晚期,预后因素较差。年轻患者的乳腺癌可能更具促血管生成性。